Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Rifampicin (450mg) + Isoniazid (300mg) Tablet
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rifamail IS Tablet is a fixed-dose combination of Rifampicin and Isoniazid, two essential first-line anti-tuberculosis agents used extensively in standard TB treatment regimens. This combination improves treatment compliance and therapeutic effectiveness.
Rifampicin works by inhibiting bacterial RNA synthesis, while Isoniazid interferes with mycolic acid production in the bacterial cell wall. Together, they provide synergistic action against Mycobacterium tuberculosis.
The tablet formulation ensures accurate dosing, better patient adherence, and reduced pill burden—making it a preferred choice in national TB programs, hospitals, and clinical practice.
For PCD pharma companies, distributors, and exporters, Rifamail IS Tablet is a high-demand, fast-moving product that strengthens the anti-infective and TB therapy portfolio with strong prescriber acceptance and long-term market potential.
Common side effects may include nausea, vomiting, abdominal discomfort, loss of appetite, headache, and orange-red discoloration of body fluids. Serious side effects can include liver toxicity, peripheral neuropathy, allergic reactions, or blood disorders. Immediate medical attention is required if jaundice, severe fatigue, or tingling sensations occur.
Rifamail IS Tablet is indicated for the treatment of tuberculosis as part of combination therapy, in both intensive and continuation phases, as prescribed by a healthcare professional.
Rifamail IS Tablet should be taken exactly as prescribed, preferably on an empty stomach for optimal absorption. Regular monitoring of liver function tests is essential during therapy. Avoid alcohol consumption during treatment. Vitamin B6 (pyridoxine) supplementation may be advised to prevent nerve-related side effects.
Store Rifamail IS Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date mentioned on the pack.
Composition : Iron & calcium tonic
Composition : Iron Sucrose 20mg Injection
Composition : Elemental Iron 10mg + Folic Acid 200mcg + Vitamin B12 100mcg
Composition : Elemental Iron 100mg/5ml
Composition : Sodium Feredetate 231mg (Eq. to Elemental Iron 33mg) + Folic Acid 5mg + Vitamin B12 15mcg + Zinc Sulphate Monohydrate 5mg
Composition : Ferrous Bisglycinate 100 mg + Folic Acid 200 mcg (RDA 20%) + Vitamin B12 (Cyanocobalamin) 1 mcg (RDA 100%) + Zinc Sulphate 22.5 mg (RDA 68%) + Sorbitol base q.s. Syrup
Composition : Ferrous Bisglycinate (60mg) + Zinc bisglycinate (15mg) + Folic Acid (1mg) + Methylcobalamin (500mcg)
Composition : Ferrous Ascorbate (100mg) + Folic Acid (1.5mg) + Zinc (22.5mg)
Composition : Ferrous Fumarate 19mg + Zinc Sulphate 12mg + Folic Acid 140mcg
Composition : Ferrous Ascorbate 100mg + Folic Acid 1.5mg
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rifampicin 450mg + Isoniazid 300mg Tablet has significant demand in the anti-tubercular, respiratory care, and infectious disease segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty anti-infective portfolios.
Medical distributors and agencies can benefit from demand for tuberculosis (TB) management under strict medical supervision and national treatment guidelines. Rifampicin 450mg is a rifamycin-class antibiotic that plays a key role in anti-tubercular therapy Isoniazid 300mg is a first-line anti-tubercular agent used in the treatment and management of tuberculosis Commonly prescribed as part of combination anti-tubercular treatment regimens for susceptible forms of tuberculosis Fixed-dose combination therapy helps support treatment adherence and simplify dosing schedules Requires careful monitoring and completion of the full prescribed treatment course Frequently utilized in hospitals, chest clinics, respiratory care centers, and government healthcare programs Widely prescribed by pulmonologists, infectious disease specialists, and physicians involved in TB management This strengthens a comprehensive anti-tubercular and respiratory care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rifampicin 450mg + Isoniazid 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from institutional demand, participation in specialty healthcare markets, reliable supply chain support, repeat procurement opportunities, and attractive margins in the anti-infective segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.